期刊文献+

替加环素不良反应类型及其防治策略 被引量:15

下载PDF
导出
摘要 替加环素(tigecycline,tigcil)是首个用于临床的甘氨酰四环素类(glycylcyclines)新型广谱抗生素([1]),特别是对泛耐药致病菌(如耐甲氧西林金黄色葡萄球菌、耐青霉素肺炎链球菌、耐万古霉素肠球菌和泛耐药鲍曼不动杆菌)均具有非常高的活性,主要用于治疗成年患者复杂皮肤、软组织感染和复杂腹腔内感染,如烧伤感染、深部软组织感染等,其常见的不良反应为腹泻、恶心和呕吐等胃肠道不适,
出处 《浙江中西医结合杂志》 2016年第4期381-383,391,共4页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献25

  • 1Noskin GA.Tigecycline : a new glycylcycline for treatment ofserious infections[J].Clin Infect Dis,2005,41(suppl 5):S303-314.
  • 2Gilson M,Moachon L,Jeanne L,et al.Acute pancreatitis re-lated to tigecycline: case report and review of the literature[Jl.Scand J Infect Dis,2008,40(8):681-683.
  • 3Emmanuel 0,Christian E,Robbert van M,et al.Tigecycline-related pancreatitis : a review of spontaneous adverse eventreports[ J ].Pharmacotherapy ,2013,33( 1 ) : 63-68.
  • 4Steinberg WM.Acute drug and toxin induced pancreatitis[j].Hosp Pract,1985,20(5):95-102.
  • 5Elmore MF, Rogge JD.Tetracycline-induced pancreatitis [j].Gastroenterology, 1981,81(6):1134-1136.
  • 6Gotfried MH,Rodvold KA,Cwik M,et al.An open label clin-ical evaluation of tigecycline (TGC ) concentrations in se -lected tissues and fluids [J]. Clin Pharmacol Ther, 2005,77(S2):98.
  • 7Pieringer H,Schmekal B,Biesenbach G,et al.Severe coagu-lation disorder with hypofibrinogenemia associated with theuse of tigecycline [ J ] .Ann Hematol,2010,89 (10): 1063-1064.
  • 8Rossitto G,Piano S,Rosi S,et al.Life-threatening coagulopa-thy and hypofibrinogenaemia induced by tigecycline in apatient with advanced liver cirrhosis [ J ]. Eur J GastroenHepat ,2014,26(6):681-684.
  • 9Sabanis N,Paschou E,Gaviilaki E,et al.Hypofibrinogenemiainduced by tigecycline : a potentially life-threatening coagu-lation disorder[j].Infect Dis,2015,4(10):747-750.
  • 10Corvee S, Aubin GG.High-dose tigecycline-associated al-terations in coagulation parameters in critically ill patientswith severe infections [J]. Int J Antimicrob Ag,2015,45(4):84-95.

二级参考文献78

  • 1张池金.住院药疹患者致病药物临床分析[J].中华临床医师杂志(电子版),2011,5(11):3363-3364. 被引量:4
  • 2抗菌药物临床应用指导原则[J].中国临床药学杂志,2005,14(3). 被引量:82
  • 3牛红喜,耿龙,尚英彬,徐媛媛,宋芳吉,陈洪铎.191例重症药疹临床分析[J].中华皮肤科杂志,2006,39(9):530-532. 被引量:26
  • 4任少华.甘氨环素类药物替加环素的研究进展[J].国外医学(药学分册),2007,34(2):106-109. 被引量:11
  • 5张学军.皮肤性病学[M].6版.北京:人民卫生出版社.2005:164.
  • 6Gettig J P, Crank C W, Philbrick A H. Faropenem Medoxomil[J]. Ann Pharmacother,2008,42(1):80-90.
  • 7Kasbekar N. Tigecycline: a New Glycylcycline AntimicrobialAgent[ J ]. Am J Health Syst Pharm,2006,63(13): 1235-1243.
  • 8周迎春.静脉留置针输液患者发生静脉炎的危险因素分析[J].2010,17(5B):51-52.
  • 9Parriuo SJ.Stevens-Johoson syndrome and toxic epidormal necrolysis[J].Curr Allergy Asthma Rep,2007,7(4):243-247.
  • 10Trent JT,Halem M,French LE,et al.Toxic epidermal necrolysis and intravenous immunoglobulin:A review[J].Seminars in Cutaneous Medicine and Surgery,2006,25(2):91-93.

共引文献88

同被引文献99

引证文献15

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部